Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer

2017 ◽  
Vol 213 (4) ◽  
pp. 333-338 ◽  
Author(s):  
Yunxia Ma ◽  
Yuan Chen ◽  
Iver Petersen
2013 ◽  
Vol 23 (8) ◽  
pp. 2043-2054 ◽  
Author(s):  
Christine Kuhmann ◽  
Carmen Li ◽  
Matthias Kloor ◽  
Mariam Salou ◽  
Christoph Weigel ◽  
...  

2020 ◽  
Vol 26 (16) ◽  
pp. 4339-4348 ◽  
Author(s):  
Bin Liu ◽  
Julio Ricarte Filho ◽  
Apurva Mallisetty ◽  
Cassandra Villani ◽  
Anastasia Kottorou ◽  
...  

2020 ◽  
Vol 21 ◽  
Author(s):  
Yoonki Hong ◽  
Woo Jin Kim

: Lung cancer is the most common cancer and the leading cause of cancer-related morbidity and mortality worldwide. As early symptoms of lung cancer are minimal and non-specific, many patients are diagnosed at an advanced stage. Despite a concerted effort to diagnose lung cancer early, no biomarkers that can be used for lung cancer screening and prognosis prediction have been established so far. As global DNA demethylation and gene-specific promoter DNA methylation are present in lung cancer, DNA methylation biomarkers have become a major area of research as potential alternative diagnostic methods to detect lung cancer at an early stage. This review summarizes the emerging DNA methylation changes in lung cancer tumorigenesis, focusing on biomarkers for early detection and their potential clinical applications in lung cancer.


2003 ◽  
Vol 23 (1) ◽  
pp. 206-215 ◽  
Author(s):  
Yutaka Kondo ◽  
LanLan Shen ◽  
Jean-Pierre J. Issa

ABSTRACT The mechanism of DNA hypermethylation-associated tumor suppressor gene silencing in cancer remains incompletely understood. Here, we show by chromatin immunoprecipitation that for three genes (P16, MLH1, and the O 6-methylguanine-DNA methyltransferase gene, MGMT), histone H3 Lys-9 methylation directly correlates and histone H3 Lys-9 acetylation inversely correlates with DNA methylation in three neoplastic cell lines. Treatment with the histone deacetylase inhibitor trichostatin A (TSA) resulted in moderately increased Lys-9 acetylation at silenced loci with no effect on Lys-9 methylation and minimal effects on gene expression. By contrast, treatment with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (5Aza-dC) rapidly reduced Lys-9 methylation at silenced loci and resulted in reactivation for all three genes. Combined treatment with 5Aza-dC and TSA was synergistic in reactivating gene expression through simultaneous effects on Lys-9 methylation and acetylation, which resulted in a robust increase in the ratio of Lys-9 acetylated and methylated histones at loci showing dense DNA methylation. By contrast to Lys-9, histone H3 Lys-4 methylation inversely correlated with promoter DNA methylation, was not affected by TSA, and was increased moderately at silenced loci by 5Aza-dC. Our results suggest that reduced H3 Lys-4 methylation and increased H3 Lys-9 methylation play a critical role in the maintenance of promoter DNA methylation-associated gene silencing in colorectal cancer.


2021 ◽  
pp. 174698
Author(s):  
Lauren A. Bertocci ◽  
Jeffrey R. Rovatti ◽  
Alex Wu ◽  
Amber Morey ◽  
Diptiman D. Bose ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document